Skip Navigation LinksHome > Advocacy > Comments

Comments Archive

2010

Comments to CMS on Hospital Outpatient Prospective Payment System Proposed Rule for Calendar Year 2011 – 8/30/10
Comments to CMS on Proposed Changes to the Hospital Inpatient Prospective Payment Systems and Fiscal Year 2011 Rates – 6/17/10
Comments to FDA on Proposed Rule on Informed Consent Elements – 2/25/10

2009

Comments to FDA on Draft Guidance on Blood Donor Suitability and Blood Safety and H1N1 Pandemic - 12-3-09
Comments to CMS on Proposed 2010 Outpatient Payments for Blood Products – 08/31/09
Comments to CMS on Proposed 2010 Outpatient Payments for Stem Cell Procedures – 08/28/09 (PDF)
AABB Commends CMS for Recognizing Blood Costs in Inpatient Market Basket - 6/30/09

2008

Comments to NRC on Security and Continued Use of Cesium-137 Chloride Sources – 10/13/08
Comments to CMS on Proposed Changes to the Hospital Outpatient Prospective Payment System and CY 2009 Rates – 9/2/08
Amicus Curiae Brief of ABC, AABB and ARC in Support of LifeSouth Community Blood Centers Inc. – 8/18/08 (PDF)
Comments to The Joint Commission on Blood Management Candidate Performance Measures – 8/19/08
Summary of Draft Comments to be Submitted to TJC on Blood Management Performance Measures – 8/8/08
Comments to the FDA on Proposed Rule on Requirements for Human Blood and Blood Components Intended for Transfusion or for Further Manufacturing – 8/1/08 (PDF)
Comments to FDA on Draft Guidance for Validation of RMM for Sterility Testing of Cellular and Gene Therapy Products – 5/9/08
 

2007

Comments to FDA on Draft Guidance for Cell Selection Devices – 9/19/07
Comments to CMS on Proposed Changes to the Hospital Outpatient Prospective Payment System and CY 2008 Rates – 9/12/07
Joint Comments to U.S. Sens. Kennedy, Enzi, Clinton and Hatch on Wired for Health Care Quality Act – 6/4/07
Comments to CMS on Clinical Trial Coverage Proposal – 5/9/07

2005

Recovered Plasma Task Force Comments to FDA on Recovered Plasma – 6/23/05

2004

Comments to FDA on Electronic Records and Signatures – 7/8/04

2003

Comments to FDA on Proposed Safety Reporting Requirements – 10/13/03
Comments to CMS on Hospital Outpatient Prospective Payment System and Rates – 10/6/03 (PDF)

2002

Comments to FDA on Guidance Relating to Xenotransplantation – 5/8/02

2001

Comments to FDA on Draft Guidance Relating to Donor Incentives – 3/3/01

2000

Comments to FDA on Guidance Relating to Donor Deferral for Xenotransplantation Product Recipients – 2/23/00